| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927603 | American Heart Journal | 2015 | 10 Pages |
Abstract
Our data, from a modest-sized population of elderly STEMI patients, indicate that half-dose TNK reduces the likelihood of ICH without compromising reperfusion efficacy. These observations are hypothesis generating and warrant further confirmation in randomized clinical trials in the elderly.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul W. MD, Yinggan MA, MEd, Cynthia M. PhD, Fernado MD, PhD, Peter MD, PhD, Yves MD, Renato D. MD, PhD, Erich MD, Thierry MD, Frans MD, PhD, STREAM investigators STREAM investigators,